Wu Tsai Human Performance Alliance
Showing 331-340 of 349 Results
-
Nolan Williams
Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioNolan Williams, M.D. is a Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award and Colvin Prize). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Helen Wilson
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Wilson is a licensed clinical psychologist with expertise in the areas of trauma and life stress, women's wellness and sexual dysfunction, and lifestyle psychiatry. She provides clinical services in these areas and is Co-Director of the Lifestyle Psychiatry Clinic focused on holistic interventions incorporating physical activity, nutrition, stress management, sleep, social connection, and avoidance of risk substances. She has is also a 500 hour certified yoga instructor as has developed a group therapy program that integrates principles of yoga to support management of mood and anxiety symptoms. Dr. Wilson has completed federally funded research focused on relationships between childhood trauma and health risk behavior in adolescence and adulthood and is currently engaged in clinical research. Dr. Wilson has authored or co-authored over thirty journal articles and book chapters related to these topics, and she regularly presents her work at local and national conferences. She is lead editor of the 2023 book Facing Campus Sexual Assault and Relationship Violence With Courage: A Guide for Institutions and Clinicians on Prevention, Support, and Healing. She is currently engaged in a collaboration with Stanford Recreation and Wellness to evaluate the benefits of physical wellness and outdoor education courses.
-
Jiajun Wu
Assistant Professor of Computer Science and, by courtesy, of Psychology
BioJiajun Wu is an Assistant Professor of Computer Science and, by courtesy, of Psychology at Stanford University, working on computer vision, machine learning, robotics, and computational cognitive science. Before joining Stanford, he was a Visiting Faculty Researcher at Google Research. He received his PhD in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology. Wu's research has been recognized through the Young Investigator Programs (YIP) by ONR and by AFOSR, the NSF CAREER award, the Okawa research grant, the AI's 10 to Watch by IEEE Intelligent Systems, paper awards and finalists at ICCV, CVPR, SIGGRAPH Asia, ICRA, CoRL, and IROS, dissertation awards from ACM, AAAI, and MIT, the 2020 Samsung AI Researcher of the Year, and faculty research awards from Google, J.P. Morgan, Samsung, Amazon, and Meta.
-
Joy Wu
Gerald M. Reaven, MD Professor of Endocrinology
Current Research and Scholarly InterestsMy laboratory focuses on the pathways that regulate the differentiation of mesenchymal stem cells into the osteoblast and adipocyte lineages. We are also studying the role of osteoblasts in the hematopoietic and cancer niches in the bone marrow microenvironment.
-
Tony Wyss-Coray, PhD
D. H. Chen Professor II
Current Research and Scholarly InterestsUse of genetic and molecular tools to dissect immune and inflammatory pathways in Alzheimer's and neurodegeneration.
-
Haopeng Xiao
Assistant Professor of Biochemistry
BioUnderstanding mechanisms of metabolic regulation in physiology and disease forms the basis for developing therapies to treat diseases in which metabolism is perturbed. We devise novel mass spectrometry (MS)-based proteomics technologies, combined with data science, to systematically discover mechanisms of metabolic regulation over protein function. Our strategies established the first tissue-specific landscape of protein cysteine redox regulation during aging, elucidating mechanisms of redox signaling in physiology that remained elusive for decades. We also leverage the genetic diversity of outbred populations to systematically annotate protein function and protein-metabolite co-regulation. The aim of our research program is to develop next-generation MS-based strategies to understand mechanisms of metabolic regulation in aging, metabolic disease, and cancer, and to use this knowledge as a basis to develop translational therapeutics.
-
Sheng Xu
Professor of Anesthesiology, Perioperative & Pain Medicine (Department Research) and, by courtesy, of Electrical Engineering
BioDr. Sheng Xu is a tenured professor and the inaugural Director of Emerging Technologies in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University, with a courtesy appointment in Electrical Engineering. He earned his B.S. degree in Chemistry from Peking University and his Ph.D. in Materials Science and Engineering from the Georgia Institute of Technology. Subsequently, he pursued postdoctoral studies at the Materials Research Laboratory at the University of Illinois at Urbana-Champaign. He then spent 10 years on the faculty at UC San Diego before joining Stanford in 2025. His research group is interested in developing new materials and fabrication methods for soft electronics. His research has been presented to the United States Congress as a testimony to the importance and impact of NIH funding.
-
Fan Yang
Associate Professor of Orthopaedic Surgery and of Bioengineering
Current Research and Scholarly InterestsOur lab’s mission is to develop therapies for regenerating human tissues lost due to diseases or aging, and to build tissue engineered 3D models for understanding disease progression and informing drug discovery. We invent biomaterials and engineering tools to elucidate and modulate biology, and also use biology to inform materials and engineering design. Our work is highly interdisciplinary, and is driven by unmet clinical needs or key gaps in biology.
-
Phillip C. Yang, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.
